Trial intelligence / Profile preview

NRL0706 (Moviprep Orange) for Colon Cleansing

NCT01251237Phase 2Completed

Sponsor
Norgine
Start
Mar 2010
Primary completion
Jul 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of macrogol in colon cancer, sponsored by Norgine. Started Mar 2010; status: completed.

02

Drugs

macrogol
03

Conditions

colon cancer

Beyond the preview

Go deeper on NCT01251237.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01251237.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call